Allied Market Research published a report, titled, “Compounding Pharmacies Market by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements, Others), by Route of Administration (Oral, Topical, Others), by Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global compounding pharmacies industry was estimated at $8.12 billion in 2021, and is anticipated to hit $14.84 billion by 2031, registering a CAGR of 6.2% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape.
“Increase in prevalence of chronic disease. high adoption of non-sterile medication, increase in old age population and improved life expectancy, along with increasing awareness about compounding medications fuel growth of the compounding pharmacies market. ”
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ (245 ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ):ย https://www.alliedmarketresearch.com/request-sample/12285
๐๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ-
Advanced Pharmacy, Athenex Pharma Solutions, B. Braun Melsungen AG, Dougherty’s Pharmacy, Inc., Fresenius SE and Co. KGaA, Institutional pharmacy solutions, ITC compounding pharmacy, McGuff Companies, Inc., Nephron pharmaceuticals, New Compounding Pharma, Olympia Compounding Pharmacy, Panacea Biomatx Inc (Triangle Compounding Pharmacy), Pencol compounding pharmacy, Perrigo Company Plc (Fagron), Rx express compounding pharmacy, RX3 compounding pharmacy, Valor Compounding Pharmacy
๐๐จ๐ฏ๐ข๐-19 ๐ฌ๐๐๐ง๐๐ซ๐ข๐จ-
โพ Amidst the global health crisis, the demand for compounded medication witnessed a steep incline in 2021, due to increased demand for quite a lot of
medications for the treatment of Covid-19.
โพ Reduced manufacturing activities due to restrictions and shortage of commercially available drugs gave way to increased adoption of a compounded
medication.
โพ Moreover, FDA gave out a temporary guidance policy to the federal facilities and state-licensed pharmacies, comprising hospital pharmacies and
compounding pharmacies that are not listed with FDA as outsourcing facilities for compounding certain medication for hospitalized patients, owing to
shortage of generic drugs.
๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ ๐จ๐ง ๐๐๐๐๐-19? ๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ:ย https://www.alliedmarketresearch.com/request-for-customization/12285?reqfor=covid
Pharmacy
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง :
โฎ North America (U.S., Canada, Mexico)
โฎ Europe (Italy, Spain, Rest of Europe, Germany, France, UK)
โฎ Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
โฎ LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
The key factors driving the growth of compounding pharmacy market are increase in prevalence of chronic diseases, high acceptance of non-sterile drugs, increase in elderly population, and higher life expectancy. Moreover, growing drug failure rate, increase in popularity of personalized medicine, and massive drug shortages across the globe are some compounding pharmacies market trends further expected to boost the market growth during the forecast period. However, increase in restrictions on manufacturing of complex formulations is likely to hamper the growth of compounding pharmacies market during the forecast period. Conversely, the growth potential of emerging economies is expected to provide ample opportunities for the market growth during the forecast period.
By therapeutic area, the pain management segment dominated the market in 2021 and is expected to remain dominant during the forecast period. This can be attributed to the increasing geriatric population, rising number of surgical procedures, and rise in healthcare expenditure. On the other hand, the “other” segment is expected to witness the fastest market growth during the forecast period, owing to increase in neurological disorders and cancer cases.
๐๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง
Region wise, North America has the highestย compounding pharmacies market shareย share in compounding pharmacies industry in 2021 registering a CAGR of 5.9% during the forecast period. This is attributed to the well-established healthcare system, increase in number of geriatric patients, and supportive reimbursement policies in healthcare system and increasing number of healthcare facilities offering compounding pharmacy products. Asia pacific is projected to register the highest CAGR of 7.3% during the forecast period. The presence of a large population base, increasing per capita income, growing medical tourism industry, and rising public awareness regarding benefits of compounding medications are the key driving factors that boost the growth of the market in the region.
๐
๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐?
Q1. Which is the most influencing segment growing in the Compounding Pharmacies Market report?
Q2. What are the key trends in the Compounding Pharmacies Market report?
Q3. What is the total market value of Compounding Pharmacies Market report ?
Q4. What would be forecast period in the market report?
Q5. Which are the top companies hold the market share in compounding pharmacies market?
Q6. What is the market value of Compounding Pharmacies Market in 2031?
Q7. Which is base year calculated in the Compounding Pharmacies Market report?
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ :ย https://www.alliedmarketresearch.com/checkout-final/5a482462fd1e78869c9aca32a6e9094a
Trending Healthcare Reports :
โฎ Hip Replacement Marketย https://www.alliedmarketresearch.com/hip-replacement-market-A17084
โฎ Tendon Repair Marketย https://www.alliedmarketresearch.com/tendon-repair-market-A17088
โฎ Radiation Oncology Marketย https://www.alliedmarketresearch.com/radiation-oncology-market-A18438
โฎ Arthroscopy Devices Marketย https://www.alliedmarketresearch.com/arthroscopy-devices-market